CPA, AMI, cerebral infarction, moderate-to-severe injury, hypertension, diabetes, and COPD cardiopulmonary arrest, acute myocardial infarction, cerebral infarction, moderate-to-severe injury, hypertension, diabetes, COPD
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) All inpatients at Provincial Genegal Hospital (PGH) in 2023, 2024, and 2028 2) Inpatients referred from two target Regional Medical Centers (RMCs) and two non-target RMCs to PGH with diagnosis of cardiopulmonary arrest (CPA), acute myocardial infarction (AMI), cerebral infarction, and moderate-to-severe injury in 2023, 2024, and 2028 3) All inpatients at target RMCs in 2023, 2024, and 2028 4) Inpatients referred from target CHCs with diagnosis of CPA, AMI, cerebral infarction, and moderate-to-severe injury in 2023, 2024, and 2028 5) Patients referred from commune health centers (CHCs) to upper-level hospitals due to poor control or complications of hypertension, diabetes, and chronic obstructive pulmonary diseaase (COPD) 6) Outpatients who visited target CHCs for hypertension, diabetes, and COPD in 2023, 2024, and 2028
Exclusion criteria
Exclusion criteria: Patients whose HIS (hospital information system) records are missing necessary data required to calculate above evaluation indicators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Clinical effectiveness: Change in inpatient mortality rate, referral rate, length of stay (bed days), rate of conducting specified clinical interventions, etc. 2. Cost: Unit cost of telehealth session reflecting both direct and indirect costs incurred by the telehealth solution. 3. Impact on clinical care implementation: How telehealth changed human resources, work processes, workload, and other aspects of clinical care in target health facilities. 4. Sustainability: Prospect of long-term continuation of telehealth services after the JICA project terminates. 5. Health facility utilization: Change in the number of consultations and admissions at target health facilities. 6. Safety: Confirmation of any adverse events among patients due to telehealth. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. List of diagnostic and treatment items enabled by the telehealth deployment 2. Telehealth implementation frequency 3. Number of health staff engaged in telehealth 4. Number of health facility staff trained on telehealth | — |
Countries
Japan, Vietnam
Contacts
Japan International Cooperation Agency Vietnam Telehealth Project